Cargando…

Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy

BACKGROUND: Although several echo-Doppler methods were proposed to optimize atrioventricular (AV) delay in patients with sequential ventricular pacing, “echo-guided” AV optimization has not been widely adopted clinically. A combination of trasmitral flow (TMF) and pulmonary venous flow (PVF) measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuhara, Kenzo, Okura, Hiroyuki, Koyama, Terumasa, Kume, Teruyoshi, Neishi, Yoji, Hayashida, Akihiro, Yoshida, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454827/
https://www.ncbi.nlm.nih.gov/pubmed/26069448
http://dx.doi.org/10.1007/s12574-014-0237-x
_version_ 1782374660139122688
author Fukuhara, Kenzo
Okura, Hiroyuki
Koyama, Terumasa
Kume, Teruyoshi
Neishi, Yoji
Hayashida, Akihiro
Yoshida, Kiyoshi
author_facet Fukuhara, Kenzo
Okura, Hiroyuki
Koyama, Terumasa
Kume, Teruyoshi
Neishi, Yoji
Hayashida, Akihiro
Yoshida, Kiyoshi
author_sort Fukuhara, Kenzo
collection PubMed
description BACKGROUND: Although several echo-Doppler methods were proposed to optimize atrioventricular (AV) delay in patients with sequential ventricular pacing, “echo-guided” AV optimization has not been widely adopted clinically. A combination of trasmitral flow (TMF) and pulmonary venous flow (PVF) measurements may be beneficial to further optimize AV delay to achieve better cardiac function. The aim of this study was to assess the feasibility and usefulness of AV delay optimization by combined use of TMF and PVF. METHODS: A total of 32 patients after sequential ventricular pacemaker implantation were enrolled and studied. The optimal AV delay was defined as the timing to minimize the duration between PVF reversal (a) wave and the duration of the “A” wave of TMF. Stroke volume was measured at the “optimized” AV delay (AVD(OPT)) and was compared with that obtained at shorter (AVD(OPT) − 50 ms) and longer (AVD(OPT) + 50 ms) AV delays. RESULTS: AV optimization was feasible in 27 of 32 patients (87 %). Stroke volume at AVD(OPT) was significantly higher than that at shorter or longer AV delay (63 ± 18 ml vs. 57 ± 15 ml vs. 56 ± 16 ml, P = 0.001). CONCLUSIONS: AV delay optimization using TMF and PV flow was feasible. Usefulness of this method requires further investigation with a larger study population.
format Online
Article
Text
id pubmed-4454827
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-44548272015-06-09 Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy Fukuhara, Kenzo Okura, Hiroyuki Koyama, Terumasa Kume, Teruyoshi Neishi, Yoji Hayashida, Akihiro Yoshida, Kiyoshi J Echocardiogr Original Investigation BACKGROUND: Although several echo-Doppler methods were proposed to optimize atrioventricular (AV) delay in patients with sequential ventricular pacing, “echo-guided” AV optimization has not been widely adopted clinically. A combination of trasmitral flow (TMF) and pulmonary venous flow (PVF) measurements may be beneficial to further optimize AV delay to achieve better cardiac function. The aim of this study was to assess the feasibility and usefulness of AV delay optimization by combined use of TMF and PVF. METHODS: A total of 32 patients after sequential ventricular pacemaker implantation were enrolled and studied. The optimal AV delay was defined as the timing to minimize the duration between PVF reversal (a) wave and the duration of the “A” wave of TMF. Stroke volume was measured at the “optimized” AV delay (AVD(OPT)) and was compared with that obtained at shorter (AVD(OPT) − 50 ms) and longer (AVD(OPT) + 50 ms) AV delays. RESULTS: AV optimization was feasible in 27 of 32 patients (87 %). Stroke volume at AVD(OPT) was significantly higher than that at shorter or longer AV delay (63 ± 18 ml vs. 57 ± 15 ml vs. 56 ± 16 ml, P = 0.001). CONCLUSIONS: AV delay optimization using TMF and PV flow was feasible. Usefulness of this method requires further investigation with a larger study population. Springer Japan 2014-12-19 2015 /pmc/articles/PMC4454827/ /pubmed/26069448 http://dx.doi.org/10.1007/s12574-014-0237-x Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Investigation
Fukuhara, Kenzo
Okura, Hiroyuki
Koyama, Terumasa
Kume, Teruyoshi
Neishi, Yoji
Hayashida, Akihiro
Yoshida, Kiyoshi
Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
title Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
title_full Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
title_fullStr Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
title_full_unstemmed Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
title_short Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
title_sort feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454827/
https://www.ncbi.nlm.nih.gov/pubmed/26069448
http://dx.doi.org/10.1007/s12574-014-0237-x
work_keys_str_mv AT fukuharakenzo feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy
AT okurahiroyuki feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy
AT koyamaterumasa feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy
AT kumeteruyoshi feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy
AT neishiyoji feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy
AT hayashidaakihiro feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy
AT yoshidakiyoshi feasibilityofanovelatrioventriculardelayoptimizationmethodusingtransmitralandpulmonaryvenousflowinpatientswithsequentialventricularpacingorcardiacresynchronizationtherapy